Skip to content
General News, Medical Health Aged Care

Australian researchers present potential new treatment option for nicotine addiction

Monash University 2 mins read
Zhang Rong, Getty Images

Smokers seeking to conquer their addiction may have a new treatment option following the results from a clinical trial led by Monash University, which found a combination of varenicline and nicotine lozenges significantly improved smoking abstinence when compared with varenicline alone.

Both varenicline and nicotine lozenges (a form of nicotine replacement therapy) are medications commonly used for smoking cessation. Varenicline is the most effective single therapy currently available for smoking cessation.

The trial, titled ‘VANISH’ (Varenicline And NIcotine replacement therapy for Smokers admitted to Hospitals), included 320 adult daily smokers across five Australian public hospitals. It found that participants treated with both varenicline and nicotine lozenges had 84 per cent greater odds (chance) to abstain from smoking when self-reporting their progress at a 12-month follow up, compared with those taking varenicline alone. 

The multi-institutional study was led by Monash’s Centre for Medicine Use and Safety (CMUS) within the Monash Institute of Pharmaceutical Sciences in collaboration with other leading research institutes, including Monash University’s School of Public Health and Preventive Medicine, Flinders University and five major Australian tertiary care public hospitals, coordinated by Barwon Health. 

As far as the authors are aware, this is the first reported placebo-controlled, randomised clinical trial comparing the efficacy and safety of varenicline alone with the combination of varenicline and nicotine lozenges in hospitalised heavy smokers.

Associate Professor Johnson George, lead author of the study and smoking cessation expert from CMUS, said the fact that participants self-reported smoking abstinence at both the six and 12 months trial follow-ups, combined with the validated safety of the combination treatment, means smokers wishing to quit now have an additional pharmacological treatment option in the form of varenicline and nicotine lozenges.

“The COVID-19 pandemic limited our ability to measure biochemically validated abstinence; however, based on self-reported abstinence, the combination therapy was clearly the more effective option when compared with varenicline alone, with no compromise on safety,” said Associate Professor George. 

“As such, in the context of heavy smokers who continue to experience withdrawal symptoms when taking varenicline alone, based on our findings it is certainly worth considering introducing nicotine lozenges to their treatment regimen.”

Smoking is the leading cause of preventable disease and death in Australia. While the number of people smoking tobacco cigarettes has dramatically dropped over recent decades, concurrently a new generation of nicotine addiction has escalated due to the introduction of e-cigarettes and vaping. 

“Vaping is highly addictive and has become extremely prevalent, particularly among teenagers. However, no matter how old you are there is no place for vaping as an evidence-based smoking cessation strategy in the management of nicotine dependence,” said Associate Professor George.

“Taking this into account, the more alternative options we can provide smokers that do not involve vaping, the better.” 

The researchers targeted hospitalised heavy smokers due to how much they would benefit greatly from smoking cessation, also leading to greater benefits to the community and healthcare systems. 

“Ideally the next step would be to conduct large clinical trials to measure biochemically validated abstinence of the combination therapy, including in people with vaping addiction, and also to look at a wider range of settings,” Associate Professor George concluded. 

The five hospital partners include four Victorian hospitals - Eastern Health, Peninsula Health, Barwon Health, Monash Health and Queen Elizabeth Hospital (Adelaide). 

This paper has been published in JAMA Network Open.



Contact details:

Kate Carthew

0447 822 659 


More from this category

  • General News
  • 16/07/2024
  • 17:10
MGA Entertainment

MGA Entertainment and Zapf Creation AG Complete Merger Forming MGA Zapf Creation GmbH

LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) -- MGA Entertainment and Zapf Creation AG Complete Merger Forming MGA Zapf Creation GmbHLOS ANGELES; 16 July 2024 – MGA Entertainment, Inc. (MGA), one of the largest privately held toy and entertainment companies in the world, today announced that the merger with Zapf Creation AG (Zapf), Europe’s leading manufacturer of nurturing dolls, first announced in October 2023 has been completed, creating the new wholly-owned subsidiary MGA Zapf Creation GmbH.“After more than 20 years working closely as two separate companies, Zapf Creation has joined the MGA family and we welcome them as a part of MGA,” said Isaac Larian, Founder and…

  • Biotechnology, Medical Health Aged Care
  • 16/07/2024
  • 13:13
Monash University

New study finds Victoria’s approach to post-heart attack medicine strategies are inconsistent

A new study led by Monash University has revealed that medicine strategies following a heart attack vary from patient to patient, despite clear clinical…

  • Contains:
  • General News, International News
  • 16/07/2024
  • 13:00
Monash University

Green, grey, smart solutions transform informal settlements with improved water, sanitation and climate resilience

The successful completion of novel community upgrades in Makassar, Indonesia, signals a potential new approach for millions living in urban informal settlements. 16 July 2024,Makassar – Today, residents in Makassar came together with MonashUniversity (Australia) and Hasanuddin University (Indonesia) to celebrate the completion ofcommunity upgrades that aim to improve living conditions and enhance resilience in informalsettlements. The innovative neighbourhood-scale upgrades, supported by the Australian and IndonesianGovernments, are the culmination of an extensive program of collaboration and engagementwith community and government, resulting in a suite of constructed upgrades that strengthenclimate resilience and provide access to critical sanitation and water services that…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.